Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
monoclonal antibody
Biotech
AstraZeneca IL-33 drug fails to improve COPD breathing in ph. 2
The study missed the primary endpoint of demonstrating an improvement in the amount of air that a person can exhale versus placebo.
James Waldron
Sep 8, 2024 9:45am
AbbVie axes Alzheimer's program amid 'evolving landscape'
Jul 25, 2024 10:49am
Marea ropes in $190M for clinical-stage cardiometabolic program
Jun 18, 2024 7:00am
Annexon's Guillain-Barré drug reduces disability in phase 3
Jun 4, 2024 9:21am
Zenas bags $200M series C to reach a handful of key mAB readouts
May 7, 2024 7:00am
UPDATE: Amgen axes an obesity asset, zooms in on MariTide
May 2, 2024 6:16pm
